infliximab-abda (Renflexis)

From Aaushi
Jump to navigation Jump to search
[1][2]

Introduction

Biosimilar to infliximab. FDA-approved April 2017

More general terms

References

  1. ↑ Brooks M FDA Clears Second Remicade Biosimilar (Renflexis) Medscape. April 21, 2017 http://www.medscape.com/viewarticle/878963
  2. ↑ Renflexis. HIGHLIGHTS OF PRESCRIBING INFORMATION https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/761054lbl.pdf
Retrieved from "https://aaushi.info/w/index.php?title=A53253&oldid=965754"